Evidence map›Paper›PMID 42675051›Full record

ArticleBlood cancer journal2026

Correction: Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study.

Doris K Hansen, Danai Dima, Hira Mian, Jakob Devos, Ruta Brazauskas, Temitope Oloyede, Aimaz Afrough, Nausheen Ahmed, Larry D Anderson, Rahul Banerjee and 20 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors.

Doris K Hansen *H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.ORCID http://orcid.org/0000-0002-9813-3578
Danai Dima *University of Washington/Fred Hutchinson Cancer Center, Seattle, WA, USA.
Hira Mian *McMaster University/Juravinski Cancer Centre, Hamilton, ON, Canada.ORCID http://orcid.org/0000-0003-1584-1067
Jakob DevosCIBMTR (Center for International Blood and Marrow Transplant Research), Milwaukee, WI, USA.
Ruta BrazauskasMedical College of Wisconsin, Milwaukee, WI, USA.
Temitope OloyedeCIBMTR (Center for International Blood and Marrow Transplant Research), Milwaukee, WI, USA.
Aimaz AfroughUniversity of Washington/Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0003-2645-8557
Nausheen AhmedUniversity of Kansas Medical Center, Kansas City, KS, USA.ORCID http://orcid.org/0000-0003-4336-4982
Larry D AndersonUT Southwestern Medical Center/Harold C. Simmons Comprehensive Cancer Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-6531-9595
Rahul BanerjeeUniversity of Washington/Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0003-3781-5441
Jesus G BerdejaTennessee Oncology, Nashville, TN, USA.ORCID http://orcid.org/0000-0003-4362-0376
Aram BidikianYale School of Medicine/Yale Cancer Center, New Haven, CT, USA.
Binod DhakalMedical College of Wisconsin, Milwaukee, WI, USA.ORCID http://orcid.org/0000-0002-4377-9742
Ajoy DiasNational Cancer Institute, Bethesda, MD, USA.
Yvonne EfeberaOhioHealth, Columbus, OH, USA.
Muhammad Salman FaisalOU Health Stephenson Cancer Center, Oklahoma City, OK, USA.
Lohith GowdaYale School of Medicine/Yale Cancer Center, New Haven, CT, USA.
Hamza HashmiMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-4129-5867
Abu-Sayeef MirzaH. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.ORCID http://orcid.org/0000-0002-1875-8966
Meera MohanMedical College of Wisconsin, Milwaukee, WI, USA.ORCID http://orcid.org/0000-0002-6913-6526
Ravi NarraMedical College of Wisconsin, Milwaukee, WI, USA.
Ashley E RoskoOhio State University Comprehensive Cancer Center-James Cancer Hospital, Columbus, OH, USA.
Mark SchroederWashington University School of Medicine/Siteman Cancer Center, St. Louis, MO, USA.ORCID http://orcid.org/0000-0003-4924-8990
Taiga NishihoriH. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.ORCID http://orcid.org/0000-0002-2621-7924
Heather LandauMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-3152-1189
Saad UsmaniMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-5484-8731
Marcelo C PasquiniCleveland Clinic, Cleveland, OH, USA.
Othman S AkhtarCIBMTR (Center for International Blood and Marrow Transplant Research), Milwaukee, WI, USA. oakhtar@mcw.edu.
Surbhi SidanaStanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-3288-7614
Krina K PatelThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-8894-027X

Funding

Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
NCI NIH HHS U24 CA076518
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42675051
PMCPMC13530125

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.